Cytheris

About:

Cytheris is biopharmaceutical company focused on the R&D of therapies for immune modulation.

Website: http://www.cytheris.com

Top Investors: Caisse de Depot et Placement du Quebec, Omnes Capital, Ardian, Forbion Capital Partners, Innovation Capital

Description:

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).